GSK

GSK R&D to Revenue

22.98%Fiscal year

Period ending:

GSK FY R&D/Revenue%
GSK FY R&D/Revenue25.74%-2.76%
1986-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

GSK r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 41 observations from Jun 30, 1986 to Dec 31, 2025.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
22.9834%
17.5198%
17.2942%
16.4916%
17.76%
13.1353%
12.5763%
11.8685%
12.8039%
12.4816%
14.2959%
14.4962%
12.9636%
13.1928%
13.4553%
15.1557%
14.0052%
14.7216%
14.3335%
14.8848%
14.4783%
14.5302%
13.0171%
13.6715%
12.4715%
13.972%
14.947%
14.5685%
14.386%
13.9192%
14.6806%
0%
15.1697%
14.9899%
14.5264%
13.9829%
13.2117%
12.5681%
11.1705%
8.5583%
7.9076%

Compare r&d to revenue

All GSK financial metrics · GSK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.